CoChat

Acceptance and Commitment Therapy to support medication decision-making and quality of life in women with breast cancer: protocol for a pilot randomised controlled trial

Open access

Published version of a preprint

The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index; 46 of the 81 sources its claims cite were checked for support.

Abstract

Background: Adherence to adjuvant endocrine therapy is affected by medication side-effects and associated distress. Previous interventions focused on educating women to enhance adherence have proved minimally effective. We co-designed an Acceptance and Commitment Therapy (ACT) intervention to enhance medication decision-making and quality of life by targeting a broader range of factors, including side-effect management and psychological flexibility. This study aims to establish key trial parameters, assess the acceptability of the intervention and the extent to which it can be delivered with fidelity, and to demonstrate “proof of principle” regarding its efficacy on primary and process outcomes. Methods: The ACTION intervention includes an individual 1:1 ACT session followed by three group sessions involving 8–10 women and two practitioner psychologists. Participants are also provided with access to a website containing evidence-based methods for self-managing side-effects. The ACT sessions were adapted during the COVID-19 pandemic to be remotely delivered via video conferencing software. To evaluate the feasibility and acceptability of this intervention, a multi-site, exploratory, two-arm, individually randomised external pilot trial with a nested qualitative study will be undertaken. Eighty women with early stage breast cancer prescribed adjuvant endocrine therapy will be randomised (1:1) to receive treatment as usual or treatment as usual plus the ACTION intervention. The planned future primary outcome is medication adherence assessed by the ASK-12 measure. Progression to a phase III RCT will be based on criteria related to recruitment and follow-up rates, acceptability to patients, competency and fidelity of delivery, and proof of principle for change in medication adherence. Discussion: This external pilot trial will be used to ascertain the feasibility of undertaking a future phase III RCT to definitively evaluate an ACT-based intervention to support medication taking behaviour and quality of life in women with early stage breast cancer on adjuvant endocrine therapy. Trial registration: ISRCTN: 12027752. Registered 24 December 2020, https://doi.org/10.1186/ISRCTN12027752 © 2022, The Author(s).

Overview

CoChat Summary

TL;DR

This is a protocol for a multi-site, two-arm external pilot RCT of a remotely delivered Acceptance and Commitment Therapy (ACT) intervention (“ACTION”) plus treatment as usual versus treatment as usual alone for women with early-stage breast cancer on adjuvant endocrine therapy. The study is designed to test feasibility, acceptability, therapist fidelity, and preliminary “proof of principle” for medication adherence and quality of life, not to provide definitive efficacy results.

Key findings

  • The planned sample is 80 women with early-stage breast cancer prescribed adjuvant endocrine therapy, randomized 1:1 to treatment as usual or treatment as usual plus ACTION.
  • ACTION consists of one 1-hour individual ACT session followed by three 90-minute group sessions with 8–10 women and two practitioner psychologists, plus a website and participant manual.
  • The pilot will use ASK-12 as the planned future primary outcome; proof-of-principle will be assessed by the mean change from baseline in 3- and 6-month ASK-12 scores with confidence intervals.
  • The sample-size section states that, allowing for 25% loss to follow-up, a sample of 80 patients would allow detection of an effect size of 0.432 with 65% power using a 1-sided t test at 20% significance.

Methods

  • Design: Multi-site, exploratory, individually randomized external pilot RCT with a nested qualitative study; progression to phase III depends on recruitment/follow-up, acceptability, fidelity, and proof-of-principle criteria.
  • Data/sample: Women over 18 with early-stage (1 to 3a) breast cancer taking tamoxifen, raloxifene, anastrozole, letrozole, or exemestane; recruited from oncology services at NHS hospitals in Yorkshire, UK.
  • Analysis: Primarily descriptive statistics and confidence intervals, with analyses on the intention-to-treat population; interviews will be analyzed using thematic analysis.

Limitations

  • The paper explicitly states this is a pilot and is not powered for a precise estimate of clustering by therapist effects; it is also not attempting to evaluate efficacy definitively.
  • The discussion notes that remote delivery may create problems such as harder therapeutic relationships, technical challenges, and exclusion of women without internet access or a private space; this is an interpretation from the text.
  • As a protocol, the paper provides no outcome results yet, so any effectiveness findings are not stated in the paper.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1186/s40814-022-00985-6

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 CONSORT diagram illustrating participant flow through the ACTION trial
Fig. 1 CONSORT diagram illustrating participant flow through the ACTION trialCC BY · PubMed Central

Verification

Claims the paper makes

26 Valid · 0 Not valid · 4 Not checked · 23 Own results and interpretations

20 more claims · 15 with their cited sources checked

Create a free account to see all 53 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 25
  • It may state two separate claims as one. 8

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 63 references

Cited by

See all 17

Metadata

Authors
Smith, S. G., Ellison, R., Hall, L., Clark, J., Hartley, S., Mason, E., Metherell, J., Olivier, C., Napp, V., Naik, J., Buckley, S., Hirst, C., Hartup, S., Neal, R. D., Velikova, G., Farrin, A., Collinson, M., & Graham, C. D.
Affiliations
  • University of Leeds (GB)
  • St James's University Hospital (GB)
  • Harrogate and District NHS Foundation Trust (GB)
  • Mid Yorkshire Hospitals NHS Trust (GB)
  • Queen's University Belfast (GB)
Corresponding author
Smith, Samuel G.
Venue
Pilot and Feasibility Studies
Published
2022-02-08
Volume
8
Issue
1
Pages
33-33
ISSN
2055-5784 (ISSN-L)
OpenAlex
W4225985130
Cited by
17
References
62
Citations by year
2026: 1 · 2025: 2 · 2024: 2 · 2023: 8 · 2022: 4
FWCI
1.67
Type
journal article
Language
en
Open access
Licence
Locations
  • Pilot and Feasibility Studies (publishedVersion, cc-by)
  • Research Square (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
  • Strathprints: The University of Strathclyde institutional repository (University of Strathclyde) (acceptedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (submittedVersion)
  • Research Portal (Queen's University Belfast) (submittedVersion, cc-by)
Funders
yorkshire cancer research (L417)
Topics
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
  • Social Sciences › Psychology › Clinical Psychology › Mindfulness and Compassion Interventions
  • Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
Keywords
acceptance and commitment therapy, adjuvant endocrine therapy, breast cancer, medication adherence, medication decision-making, quality of life, psychological flexibility, treatment acceptability, feasibility, early breast cancer

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Acceptance and Commitment Therapy to support medication decision-making and quality of life in women with breast cancer: protocol for a pilot randomised controlled trial. https://app.cochat.ai/papers/10.1186/s40814-022-00985-6
The paper
Smith, S. G., Ellison, R., Hall, L., Clark, J., Hartley, S., Mason, E., Metherell, J., Olivier, C., Napp, V., Naik, J., Buckley, S., Hirst, C., Hartup, S., Neal, R. D., Velikova, G., Farrin, A., Collinson, M., & Graham, C. D. (2022). Acceptance and Commitment Therapy to support medication decision-making and quality of life in women with breast cancer: protocol for a pilot randomised controlled trial. Pilot and Feasibility Studies. https://doi.org/10.1186/s40814-022-00985-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.